85 results
Page 3 of 5
8-K
EX-10.1
h6ddlh4bnyh b2y54
24 Mar 21
NeuroBo Pharmaceuticals Receives Approval for Amendment of Contingent Value Rights for Gemcabene
8:15am
8-K
EX-10.1
360c13pf
21 Jan 21
NeuroBo Pharmaceuticals Announces $10.0 Million Private Placement
5:03pm
8-K
EX-2.1
f5oa5 sp9
6 Jan 21
NeuroBo Pharmaceuticals Acquires ANA Therapeutics for Late-Stage Oral Antiviral Development Program
4:05pm
424B5
coq7zs6p
15 Apr 20
Prospectus supplement for primary offering
5:19pm
8-K
EX-10.1
nk4stwene
15 Apr 20
NeuroBo Pharmaceuticals Announces $7.5 Million Registered Direct Offering
5:13pm
8-K
EX-10.3
lliinmi5 pjzkr0
30 Dec 19
Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo Pharmaceuticals
9:04pm
8-K
EX-10.2
synk s9bifxlhjxq6x
30 Dec 19
Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo Pharmaceuticals
9:04pm
8-K
EX-10.1
fokn827qzh u2t722
30 Dec 19
Gemphire Therapeutics Announces Expected Closing Date of Merger with NeuroBo Pharmaceuticals
9:04pm
424B3
ljbx alk5qy
6 Nov 19
Prospectus supplement
9:15am
S-4/A
EX-8.2
me5bqq fn0k5z3el
10 Oct 19
Registration of securities issued in business combination transactions (amended)
9:35pm
S-4/A
fdh xce8pfez
10 Oct 19
Registration of securities issued in business combination transactions (amended)
9:35pm
S-4/A
EX-10.35
v19ob
10 Oct 19
Registration of securities issued in business combination transactions (amended)
9:35pm